INTRODUCTION
Influenza B viruses cause epidemics of influenza in people at approx. 4-to 6-year cycles (Stuart-Harris & Schild, 1976) and have been associated with Reye's syndrome, an acute encephalopathy of children (Corey et al., 1976) . Although antigenic drift has been shown to occur in these viruses (Chakraverty, 1972; Schild et al., 1973) , no major antigenic shift has been reported and the minor antigenic changes occur less frequently than in influenza A viruses. The lack of antigenic shift in influenza B virus may be due to the absence of a gene pool of influenza B viruses in animals (Pereira, 1969) , but the relatively slow antigenic drift in these viruses has not been explained.
There is no a priori reason why antigenic drift in influenza B viruses should be different from influenza A viruses. The eight RNA segments code for at least eight polypeptides analogous to those of A viruses (Racaniello & Palese, 1979) and, as in influenza A, the RNA segments of influenza B viruses have common sequences at their ends (Skehel & Hay, 1978) , although these are different from influenza A viruses. The only reported differences are that the gene segments of influenza B viruses are larger than for the influenza A viruses (Desselberger & Palese, 1978) and preliminary studies with three monoclonal antibodies to the haemagglutinin (HA) molecule of the prototype strain B/Lee/40 suggest a low frequency of isolation of antigenic variants (Lubeck et al., 1980) .
In comparison with the detailed information on antigenic drift in influenza A viruses (Laver et al., 1979; Webster & Laver, 1980) , little or no information is available about influenza B viruses. We present here a study of antigenic drift in the HA molecule of influenza B viruses using monoclonal antibodies which were used to determine the frequency of antigenic variation, the number of non-overlapping antigenic determinants and to determine whether variants selected with monoclonal antibodies could be distinguished from wild-type viruses with post-infection ferret antisera. (Table  1) were grown in the ailantoic cavity of 11-day-old embryonated hens' eggs. When necessary, the virus was concentrated by adsorption to and elution from chicken erythrocytes, and purified by banding on sucrose gradients as previously described (Laver & Webster, 1968 ).
An inhibitor-resistant strain of B/HK/8/73 was prepared by growing the virus in embryonated eggs in the presence of horse serum and foetal calf serum from which immunoglobulins had been removed. The variants that were not inhibited by calf and horse serum were used to screen for the production of antibodies in hybridoma cells.
Serological assays. Haemagglutination inhibition (HI) tests followed the method of Fazekas de St. Groth & Webster (1966) , using sera or ascitic fluid treated with receptor-destroying enzyme (Robinson & Dowdle, 1959) . Neuraminidase inhibition (NI) tests were performed according to Aymard-Henry et al. (1973) , and indirect enzyme-linked immunosorbent assays (ELISA) according to Ruitenberg et al. (1976) , as modified by van Wyke et al. (1980) .
Preparation of hybridoma cell lines. Hybridoma cell lines were prepared by fusion of the 8-azaguanine-resistant clone of MOPC-21 myeloma cells (P3/X63-AgS) with spleen cells of immunized Balb/c mice using polyethylene glycol (Kohler & Milstein, 1976) as previously described for influenza virus (Koprowski et al., 1977) . The mice received two doses of 1000 HA units of purified B/HK/8/73 virus given 2 months apart. The culture fluids from the fused cells were screened by ELISA, HI and NI tests with inhibitor-resistant influenza viruses for the detection of antibodies. Cultures producing antibody to the HA or neuraminidase (NA) were cloned in soft agar and injected intraperitoneally into pristane-treated mice (Koprowski et al., 1977) . Ascitic fluid was collected 7 to 10 days later and used in the assay.
Additional cloning of the hybridoma lines provided preliminary evidence that the antibodies were monoclonal. The antibodies produced after each cloning reacted identically against a large panel of natural influenza variants in HI tests. The panel of monoclonal antibodies used in these studies originated from hybridomas prepared from different immunized mice. Post-infection ferret sera were prepared as previously described (Kendal et al., 1977) .
Selection of antigenic variants and determination of frequency. Antigenic variants were selected according to Gerhard & Webster (1978) . Briefly, monoclonal hybridoma antibody plus cloned parent virus were incubated together for 30 min at 20 °C. This mixture was inoculated into l 1-day-old chick embryos. The viruses that grew in the presence of monoclonal antibodies were harvested and 'cloned' twice at limiting dilutions'in 11-day-old embryonated hens' eggs.
RESULTS

Specificity of the monoclonal antibodies
The antibodies produced in the hybridoma lines were specific for the HA molecule of B/HK/8/73 viruses (Table 1) and did not react with influenza A viruses (results not shown). The 12 monoclonal antibodies used in this study were tested against a panel of influenza B isolates and each monoclone gave a different pattern of reactivity, establishing that the monoclonal antibodies were directed against different antigenic determinants (Table 1) .
Antigenic drift in influenza B viruses and the co-circulation of antigenically distingu&hable viruses
Monoclonal antibodies to the HA molecule of B/HK/8/73 showed that antigenic drift had occurred in influenza B isolates (Tables 1, 2) and that the B/HK/8/73 strain is more closely (Table 2) . Influenza B viruses isolated during the same outbreak were examined with a panel of monoclonal antibodies to determine if they were antigenically homogeneous (Table 2) . Although significant antigenic drift had occurred in the influenza B isolates, it is apparent that at least two different antigenic variants were co-circulating in Hannover during the outbreaks of 1978 and 1979 and in Singapore in 1980. In each case, one of the variants showed some antigenic reactivity in at least five antigenic sites with the B/HK/8/73 strain, whereas the co-circulating strain showed no reactivity with B/HK/8/73 at the 12 different antigenic determinants tested.
Antigenic drift in influenza B viruses detected with different monoelonal antibodies to the haemagglutinin (HA) of B/Hong
Antigenic drift in recent influenza B viruses and the co-circulation of antigenieally distinguishable influenza B viruses*
Among the more recent isolates, B/Singapore/222/79 (the current vaccine strain) is similar to B/England/65/76 and to the isolates from 1980 (Table 2 ). An influenza B strain isolated from a Reye's syndrome patient (B/Oregon/5/80) did not show any antigenically distinguishable properties with this panel of monoclonal antibodies.
Frequency of antigenic variation in influenza B viruses
Previous studies using a clonal preparation of influenza A virus have shown that the frequency of variant HA molecules was between 1 in 104.5 and 1 in 107 (with a mean of approx. 1 in 105) when estimated with a single monoclonal antibody (Yewdell et al., 1979; Webster & Laver, 1980) and was less than 1 in 101° when monoclonal antibodies from two non-overlapping antigenic determinants were used in combination. All influenza A variants so far examined show a single amino acid substitution in the HA1 polypeptide of the HA molecule.
The frequency of antigenic variants in cloned preparations of influenza B/HK/8/73 was determined with the above panel of monoclonal antibodies to the HA (Table 3) . Each variant was not inhibited in HI tests by the monoclonal antibody used in its selection. The results show that the frequency of variation ranged from approx. 1 in 107.3 to levels that were undetectable. One explanation for the low levels of antigenic variants could be that the antibody preparations were not monoclonal but contained mixtures of antibodies to different non-overlapping antigenic areas. This possibility was ruled out by re-cloning the antibodysecreting hybridoma cells and re-testing the frequency of variation; the results did not change. Another possible explanation could be that different cloned preparations of influenza B/HK/8/73 may show significant differences in the frequency of antigenic variants. Four different cloned preparations of B/HK/8/73 were therefore examined and were found to give similar results to those given above.
Analysis of antigenic variants selected with monoclonal antibodies
Since the frequency of variants in the above studies was very low, it was difficult to obtain antigenic variants for detailed analysis. We circumvented this problem by inoculating large numbers of embryonated eggs with undiluted virus preparations containing dilutions of monoclonal antibodies; in this way a small number of variants were isolated (Table 4) . To obtain information on the number of non-overlapping antigenic areas on the HA molecule of the influenza B virus, variants produced were analysed with the 12 different monoclonal antibodies (Table 4) . Although the reactivity patterns suggested three groups, there was overlap between each, suggesting that this panel of monoclonal antibodies was not able to detect more than one non-overlapping antigenic area. Two monoclonal antibodies (174/1 and 290/3) reacted with all of the variants and since antigenic variants have so far not been obtained with these monoclonal antibodies, we do not know if they recognize a different antigenic area.
Analysis of antigenic variants with antisera
Previous studies with antigenic variants of influenza A viruses selected with monoclonal antibodies have shown that even though the variants were clearly distinguishable with monoclonal antibodies, only a minority could be distinguished from the parental strain with antisera (Gerhard & Webster, 1978; Webster & Laver, 1980) . To determine if the antigenic variants of B/HK/8/73 could be distinguished from parental virus with antisera, they were assayed in HI tests with post-infection ferret sera and with a hyperimmune goat antiserum (Table 5 ). The results show that six of the ten variants were significantly different from the parental virus; with ferret antisera, five of the variants had HI antibody titres which were more than 10-fold different from the parental virus. Some of the antigenic variants (16/1 and 313/2) gave higher titres with the antisera, suggesting that some mutations actually enhanced the combination of some antibodies with the HA molecule. The frequency of antigenic variation in the HA molecule of B/HK/8/73 was less than 1 in l0 s with most monoclonal antibodies. This figure is 100-to 1000-fold below that found with influenza A viruses (Yewdell et al., 1979) , suggesting that the HA of influenza B viruses is less variable than that of influenza A virus. There are several possible explanations for the lower frequency of antigenic variation in influenza B viruses that may be related to fundamental differences between influenza A and B viruses or to the failure of the monoclonal antibodies to to o0
Group Ia Table 4 . Antigenic areas on influenza B haemagglutinin 249 serum detect antigenic variants. However, we consider it unlikely that the mutation frequency in the RNA coding for the influenza B HA is less than that in influenza A viruses. Other suggestions are: (i) the majority of the mutations are lethal, i.e. there may be more functional restrictions on the conformation of the influenza B haemagglutinin molecule; (ii) influenza B transcription is less error prone than transcription in influenza A viruses; (iii) the RNA coding for the HA of influenza B viruses is partially duplicated; (iv) influenza B virus populations contain a high frequency of phenotypically mixed particles; (v) the monoclonal antibodies are not detecting single amino acid changes, so that most of the variants isolated seem to contain more than one amino acid substitution. Sequence analysis of the gene coding for the HA of influenza B viruses will resolve some of these possibilities. Alternative explanations such as differences between cloned virus preparations and/or that the antibodies were not monoclonal have been excluded experimentally. The low frequencies of antigenic variation with B/HK/8/73 are in agreement with the low frequencies obtained by Lubeck et al. (1980) with B/Lee/40.
Reactivity patterns of antigenic variants of B/Hong
Reactivity patterns of the antigenic variants established in HI tests suggested that there was only a single overlapping antigenic area on the HA molecule of influenza B viruses, although this area could be further subdivided (Table 4) . Antigenic variants selected with monoclones in group Ia were not inhibited by eight of the different monoclonal antibodies and were indistinguishable from parental virus with ferret antisera. On the other hand, most of the antigenic variants selected with antibodies in groups Ib and Ic were significantly different from the parental virus with ferret antisera. This suggests that these antigenic determinants are perhaps biologically important in antigenic drift, while the determinants affected in the variants in group Ia may be epidemiologicaUy irrelevant.
Analysis of antigenic variants of influenza A viruses selected with monoclonal antibodies shows that the majority of the variants could not be distinguished from the parental strain with rabbit or ferret antisera (Gerhard & Webster, 1978; Webster & Laver, 1980) . Only one of 30 influenza A variants examined could be distinguished with ferret sera and this variant showed a single amino acid substitution of glycine to aspartic acid at residue 144 in the HA1 polypeptide. In contrast, six out of ten of the antigenic variants of influenza B viruses examined were approx. 10-fold different from the parental virus with ferret sera. These results suggest that, although the frequency of variation in influenza viruses is lower than in influenza A viruses, more of the variants would have epidemiological potential.
The relatively small number of different monoclonal antibodies and the small number of variants used in these studies, as well as the difficulty in isolating antigenic variants, could g.G. WEBSTER AND M. T. BERTON mean that we have too few monoclonal antibodies to fully map the antigenic determinants on the HA of influenza B viruses. Nevertheless, the results do suggest that the number of non-overlapping antigenic areas on influenza B viruses is likely to be small. We have no knowledge as to whether the changes in these variants are actually in the antibody binding site or are removed from the actual site and result in large conformational changes in the molecule.
Sequence studies on the RNA coding for the HA molecule of influenza B virus, in conjunction with detailed analysis of the antigenic areas and their relationship with the tertiary structure, will provide the necessary information for understanding the molecular basis of antigenic drift in influenza B viruses and the difference from influenza A viruses. 
